english

Han JiMin Reveals Why She Eats ‘This Food’ at Night

Actress Han JiMin shared that she has been troubled by her thin face. Recently, she appeared on SBS's "Whenever I have time" and opened up about her concerns. She explained,…

최지혜기자

2025-01-09

Handok "Rezolute’s Hyperinsulinism Treatment Receives FDA Breakthrough Therapy Status"

Handok's affiliate, Rezolute, announced on the 7th (local time) that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to its treatment for hypoglycemia caused by…

Cheon Okhyeon

2025-01-08

Medytox Appeals ITC Ruling on Botulinum Toxin Case Against Hugel

Medytox has filed an appeal against the U.S. International Trade Commission’s (ITC) final ruling in its botulinum toxin lawsuit against Hugel. In response, Hugel has decided to participate in the…

Cheon Okhyeon

2025-01-07

HK inno.N's K-Cab Expands into the Oceania Market

HK inno.N's gastroesophageal reflux disease (GERD) drug, K-Cab, is expanding into the Australian and New Zealand markets. On the 6th, HK inno.N announced that it has signed a finished product…

Cheon Okhyeon

2025-01-06

여에스더, "성형설? 칼 안댔다"...56세 때 ‘이것’ 후 광대뼈 들어가

가정의학과 전문의 겸 사업가 여에스더(59)가 성형설을 해명했다. 2일 방송된 KBS 2TV ‘박원숙의 같이 삽시다’에서 박원숙, 혜은이는 제주도에 있는 홍혜걸, 여에스더 부부의 집을 방문했다. 박원숙은 “무슨 대학생 부부 같다”라고 홍혜걸, 여에스더와…

Lee Jiwon

2025-01-03

Curocell Submits Korean Approval Application for ‘Rimcarto’

Curocell announced on the 30th that it has submitted a marketing authorization application to the Ministry of Food and Drug Safety (MFDS) for its next-generation CAR-T therapy, 'Rimcarto (Anbal-cel)'. CAR-T…

Jang Jawon

2024-12-30

SK Bioscience and Sanofi Partner to Develop Next-Generation Pneumococcal Vaccine

SK Bioscience is teaming up with global pharmaceutical company Sanofi to jointly develop a next-generation pneumococcal conjugate vaccine. The collaboration aims to penetrate the 14-trillion KRW global pneumococcal vaccine market…

Cheon Okhyeon

2024-12-23

Samsung Life Science Fund Invests in U.S. Biotech ‘Generate Biomedicines’

Samsung announced on the 18th that it has invested in the U.S.-based biotech company Generate Biomedicines through its Life Science Fund. The Samsung Life Science Fund is a venture capital…

Cheon Okhyeon

2024-12-18